Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Multi-Niche Human Bone Marrow On-A-Chip for Studying the Interactions of Adoptive CAR-T Cell Therapies with Multiple Myeloma

April 2024 Bioprinting, Bioprocessing, Blood, Cancer, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate

April 2024 Bioprinting, Cancer, Cell Therapy, Clinical, Immunomodulation, Tissue Engineering

High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia

March 2024 Bioprocessing, Cell Therapy, Clinical, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation

Development of an Allogeneic, Anti-Inflammatory Bone Marrow Stromal Cell Therapy for Chronic Low Back Pain Patients with Modic Type 1 Changes

March 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Pain, Tissue Engineering

Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy–induced ovarian damage in a mouse model

February 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Tissue Engineering

Mesenchymal Stem Cell Therapy to Rescue Airway Hyperreactivity in a Mouse Model of Neonatal Continuous Positive Airway Pressure

February 2024 Bioprocessing, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung

Multiplex Single-Cell Bioprinting for Engineering of Heterogeneous Tissue Constructs with Subcellular Spatial Resolution

February 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Tissue Engineering

The potent paracrine effect of umbilical cord mesenchymal stem cells mediates mitochondrial quality control to restore chemotherapy-induced damage in ovarian granulosa cells

February 2024 Bioprocessing, Cancer, Cell Therapy, Clinical, Drug Screening, Immunomodulation

3D printing modality effect: Distinct printing outcomes dependent on selective laser sintering (SLS) and melt extrusion

February 2024 Bioprinting, Cell Therapy, Clinical, MedTech, Devices, & Materials, Tissue Engineering

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

February 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email